Importance of bcl-2/IgH rearrangement in survival of de novo diffuse large B cell lymphomas.

被引：0
|
作者：
Kerbauy, FR [1 ]
Colleoni, GWB [1 ]
Duarte, LCC [1 ]
Alves, AC [1 ]
Aguiar, KCC [1 ]
Seixas, MT [1 ]
Silva, MRR [1 ]
机构：
[1] Univ Fed Sao Paulo, Discipline Hematol & Hemotherapy, EPM, Sao Paulo, Brazil
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4696
引用
收藏
页码：290B / 290B
页数：1
相关论文
共 50 条
  • [41] DETECTION OF BCL-2 GENE MAJOR BREAKPOINT REGION REARRANGEMENT IN HUMAN B-CELL LYMPHOMAS
    强雅维
    施秉银
    Journal of Xi'an Medical University, 2000, (01) : 5 - 11
  • [42] Diffuse large B-cell lymphomas contain centrosome aberrations at higher frequencies as compared to follicular lymphomas.
    Schweizer, S
    Neben, K
    Lichter, P
    Krause, U
    Giesecke, C
    Müller-Hermelink, HK
    Ho, AD
    Ott, G
    Krämer, A
    BLOOD, 2001, 98 (11) : 333A - 333A
  • [43] Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas
    Wenzl, Kerstin
    Troppan, Katharina
    Deutsch, Alexander J. A.
    Linkesch, Werner
    Neumeister, Peter
    Beham-Schmid, Christine
    BLOOD, 2013, 122 (21)
  • [44] PROGNOSTIC CORRELATION OF CELL-OF-ORIGIN AND MYC, BCL-2 AND BCL-6 STATUS IN HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMAS
    Rusconi, C.
    Crucitti, L.
    Re, A.
    Bandiera, L.
    Spina, M.
    Gini, G.
    Paulli, M.
    Lucioni, M.
    Facchetti, F.
    Goteri, G.
    Canzonieri, V.
    Lorenzi, L.
    Balzarini, P.
    Fisogni, S.
    Riboni, R.
    Malfitano, A.
    Bonfichi, M.
    Moioli, M. C.
    Nichelatti, M.
    Melle, F.
    Motta, G.
    Pileri, S. A.
    Cairoli, R.
    HAEMATOLOGICA, 2019, 104 : 114 - 115
  • [45] Similar prognosis of transformed and de novo diffuse large B-cell lymphomas in patients treated with immunochemotherapy
    Sorigue, Marc
    Garcia, Olga
    Joao Baptista, Maria
    Sancho, Juan-Manuel
    Tapia, Gustavo
    Luis Mate, Jose
    Feliu, Evarist
    Navarro, Jose-Tomas
    Ribera, Josep-Maria
    MEDICINA CLINICA, 2017, 148 (06): : 243 - 249
  • [46] Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas
    Grange, F
    Petrella, T
    Beylot-Barry, M
    Joly, P
    D'Incan, M
    Delaunay, M
    Machet, L
    Avril, MF
    Dalac, S
    Bernard, P
    Carlotti, A
    Esteve, E
    Vergier, B
    Dechelotte, P
    Cassagnau, E
    Courville, P
    Saiag, P
    Laroche, L
    Bagot, M
    Wechsler, J
    BLOOD, 2004, 103 (10) : 3662 - 3668
  • [47] The significance of P53 and Bcl-2 protein expression in patients with primary gastrointestinal diffuse large B-cell lymphomas
    Cakmak, Erol
    Eser, Bulent
    Sari, Ismail
    Altuntas, Fevzi
    Canoz, Ozlem
    Ozkan, Metin
    Er, Ozlem
    Cetin, Mustafa
    Unal, Ali
    ANNALS OF ONCOLOGY, 2004, 15 : 162 - 162
  • [48] Interphase FISH defines characteristic chromosomal abnormalities in diffuse large B-cell lymphomas.
    Pickering, D
    Dave, B
    Sanger, W
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 334 - 334
  • [49] Prognostic significance of CD21 expression in diffuse large B-cell lymphomas.
    Yamaguchi, M
    Ogawa, S
    Oka, K
    Taniguchi, M
    Ito, M
    Nishii, K
    Kobayashi, T
    Shiku, H
    BLOOD, 2002, 100 (11) : 351A - 351A
  • [50] ALTERATIONS OF THE BCL-2, C-MYC AND P53 GENES IN DIFFUSE LARGE CELL LYMPHOMAS
    FARRUGIA, M
    DUAN, LJ
    BERINSTEIN, N
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 265 - 265
12345